Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Cisplatin activates USP9X. 2 / 2

| 2

➶

reach

"USP9X mRNA expression predicts clinical outcome for esophageal squamous cell carcinoma treated with cisplatin based therapy."

31983659

➶

reach

"The purpose of this study was to explore the predictive effects of USP9X on advanced ESCC patients treated with cisplatin based regimens."

31983659

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...